drugset / Trial / NCT06395610
Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers
Non-randomizedCrossoverOpen-labelOther
Summary
The objective of this study is to investigate the effect of the interaction of Erythromycin (CYP3A4/5 moderate inhibitor) on the pharmacokinetic of CHF6001 (CYP3A4/5 substrate) in Healthy Volunteers.
Timeline
- Start
- 2024-03-28
- Primary completion
- 2024-06-18
- Completion
- 2024-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erythromycin | Small molecule | — | Oral |
| Subject | TRANIMILAST | Small molecule | — | — |